Appraisal CommitteeAppraisal Panel, HTA Appraisal Panel
An appointed group that deliberates on clinical, economic and other relevant evidence to make a health technology recommendation within an institution’s decision framework.
HTA & Reimbursement
Terms for how health technology assessment bodies appraise new technologies and reach funding decisions.
- Topic: HTA & Reimbursement
- 43 terms
- Editor reviewed
CADTHCanadian Agency for Drugs and Technologies in Health, Canada's Drug Agency
The Canadian Agency for Drugs and Technologies in Health, an independent national body providing evidence-based assessment recommendations for drug funding decisions.
Conditional RecommendationDiscretionary Recommendation, Conditional GRADE Recommendation
Within frameworks such as GRADE, a recommendation indicating benefits probably outweigh harms but with less certainty, giving patient preferences a larger role.
Coverage DecisionFunding Decision, Payer Coverage Ruling, Coverage Determination
The formal determination by a payer or assessment body regarding whether, and under what conditions, a technology will be reimbursed.
Decision CriteriaAppraisal Criteria, Decision Factors
The specific factors, such as cost-effectiveness and clinical benefit, an assessment body formally considers when reaching a funding recommendation.
Deliberative ProcessDeliberation, Reasoned Deliberation
A structured process of reasoned discussion of evidence and perspectives, used to reach well-justified decisions amid uncertainty or competing values.
Early Health Technology AssessmentEarly HTA, Early Modelling
The assessment of a health technology during development to inform design, evidence generation, pricing and market-access strategy.
EUnetHTAEuropean Network for HTA, EU HTA Network
The European Network for Health Technology Assessment, a collaborative network promoting methodological consistency and reducing duplication across EU member states.